Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 20001 - 20025 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Cupric oxide	Approved	H2AFX	3014	downregulated	cupric oxide results in decreased expression of H2AFX mRNA	11q23.3	A21783
Cupric oxide	Approved	HBP1	26959	upregulated	cupric oxide results in increased expression of HBP1 mRNA	7q22.3	A21783
Cupric oxide	Approved	HES1	3280	upregulated	cupric oxide results in increased expression of HES1 mRNA	3q29	A21783
Cupric oxide	Approved	HEY1	23462	upregulated	cupric oxide results in increased expression of HEY1 mRNA	8q21.13	A21783
Cupric oxide	Approved	HINT3	135114	upregulated	cupric oxide results in increased expression of HINT3 mRNA	6q22.32	A21783
Cupric oxide	Approved	HIST1H2AM	8336	upregulated	cupric oxide results in increased expression of HIST1H2AM mRNA	6p22.1	A21783
Cupric oxide	Approved	HIST2H2AA4	723790	upregulated	cupric oxide results in increased expression of HIST2H2AA4 mRNA	1q21.2	A21783
Cupric oxide	Approved	HIST2H2AB	317772	upregulated	cupric oxide results in increased expression of HIST2H2AB mRNA	1q21.2	A21783
Cupric oxide	Approved	HMGB2	3148	downregulated	cupric oxide results in decreased expression of HMGB2 mRNA	4q34.1	A21783
Cupric oxide	Approved	HMOX1	3162	upregulated	cupric oxide results in increased expression of HMOX1 mRNA	22q12.3	A21785 A21781
Cupric oxide	Approved	HNRNPH2	3188	upregulated	cupric oxide results in increased expression of HNRNPH2 mRNA	Xq22.1	A21783
Cupric oxide	Approved	HRH1	3269	upregulated	cupric oxide results in increased expression of HRH1 mRNA	3p25.3	A21783
Cupric oxide	Approved	HSF2	3298	upregulated	cupric oxide results in increased expression of HSF2 mRNA	6q22.31	A21783
Cupric oxide	Approved	HSP90AA1	3320	upregulated	cupric oxide results in increased expression of HSP90AA1 mRNA	14q32.31	A21783
Cupric oxide	Approved	HSPA13	6782	upregulated	cupric oxide results in increased expression of HSPA13 mRNA	21q11.2	A21783
Cupric oxide	Approved	HSPA6	3310	upregulated	cupric oxide results in increased expression of HSPA6 mRNA	1q23.3	A21783 A21781
Cupric oxide	Approved	HSPB8	26353	upregulated	cupric oxide results in increased expression of HSPB8 mRNA	12q24.23	A21783
Cupric oxide	Approved	HSPH1	10808	upregulated	cupric oxide results in increased expression of HSPH1 mRNA	13q12.3	A21783
Cupric oxide	Approved	HTRA3	94031	upregulated	cupric oxide results in increased expression of HTRA3 mRNA	4p16.1	A21783
Cupric oxide	Approved	HUS1	3364	upregulated	cupric oxide results in increased expression of HUS1 mRNA	7p12.3	A21783
Cupric oxide	Approved	HYLS1	219844	downregulated	cupric oxide results in decreased expression of HYLS1 mRNA	11q24.2	A21783
Cupric oxide	Approved	IGF2	3481	upregulated	cupric oxide results in increased expression of IGF2 mRNA	11p15.5	A21783
Cupric oxide	Approved	IGFBP3	3486	downregulated	cupric oxide results in decreased expression of IGFBP3 mRNA	7p12.3	A21783
Cupric oxide	Approved	ING4	51147	upregulated	cupric oxide results in increased expression of ING4 mRNA	12p13.31	A21783
Cupric oxide	Approved	INSIG1	3638	upregulated	cupric oxide results in increased expression of INSIG1 mRNA	7q36.3	A21783

Displaying entries 20001 - 20025 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability